Hemophila patients call for lifting age restriction over insurance of Kogenate FS
Now all eyes are on the Ministry for Health, Welfare and Family Affair's decision on the insurance price of Kogenate FS, a new drug for the disease. Kogenate, antihemophilic factor (recombinant) is a recombinant factor...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
